Lupin

Market Cap (₹ Cr.)

₹1,03,571

52 Week High

2,312.00

Book Value

₹313

52 Week Low

1,091.50

PE Ratio

45.76

PB Ratio

7.25

PE for Sector

39.11

PB for Sector

4.60

ROE

13.47 %

ROCE

25.91 %

Dividend Yield

0.35 %

EPS

₹49.64

Industry

Pharmaceuticals

Sector

Pharmaceuticals - Indian - Bulk Drugs & Formln

Investment Returns

In Long Term

In Short Term

1 Year

0.00%

2 Years

0.00%

3 Years

0.00%

4 Years

0.00%

5 Years

0.00%

Growth Rate

Revenue Growth

19.94 %

Net Income Growth

332.35 %

Cash Flow Change

92.30 %

ROE

277.28 %

ROCE

174.75 %

EBITDA Margin (Avg.)

75.11 %

Financial Results

Quarterly Financials	Mar 2015	Jun 2015	Sept 2015	Dec 2015	Mar 2016	Jun 2016	Sept 2016	Dec 2016	Mar 2017	Jun 2017	Sept 2017	Dec 2017	Mar 2018	Jun 2018	Sept 2018	Dec 2018	Mar 2019	Jun 2019	Sept 2019	Dec 2019	Mar 2020	Jun 2020	Sept 2020	Dec 2020	Mar 2021	Jun 2021	Sept 2021	Dec 2021	Mar 2022	Jun 2022	Sept 2022	Dec 2022	Mar 2023	Jun 2023	Sept 2023	Dec 2023	Mar 2024	Jun 2024
Revenue	2,198	2,673	2,599	2,906	3,300	3,655	2,970	3,385	2,966	2,527	2,654	2,555	2,531	2,752	2,915	3,132	3,022	2,998	3,013	2,803	2,694	2,729	3,068	2,825	2,565	3,339	2,945	2,767	2,872	2,739	2,844	2,878	2,892	3,523	3,685	4,139	3,427	4,206
Expenses	1,630	1,670	1,879	1,856	1,931	2,041	2,045	2,058	2,257	1,956	2,038	2,033	2,023	2,078	2,220	2,654	2,064	2,250	2,689	2,697	2,248	2,100	2,445	2,395	2,074	2,349	4,269	2,524	2,354	2,444	2,515	2,646	2,574	2,791	2,824	2,898	2,696	2,968
EBITDA	568	1,003	720	1,050	1,369	1,614	925	1,327	708	571	616	522	508	674	695	477	958	748	324	106	445	629	623	430	491	990	-1,324	244	517	295	329	232	317	733	861	1,241	732	1,238
Operating Profit %	24 %	34 %	22 %	32 %	40 %	41 %	29 %	36 %	20 %	20 %	19 %	17 %	17 %	17 %	16 %	11 %	29 %	22 %	5 %	-1 %	8 %	20 %	18 %	14 %	17 %	29 %	-53 %	5 %	6 %	9 %	9 %	7 %	6 %	19 %	21 %	28 %	19 %	27 %
Depreciation	79	75	75	76	80	82	86	93	105	95	95	99	100	105	105	108	109	129	133	132	125	125	126	127	125	125	130	128	131	130	138	134	146	140	149	145	290	141
Interest	2	1	2	2	20	7	3	11	8	6	11	7	10	7	10	10	8	10	12	19	11	9	9	11	12	15	18	16	25	20	18	31	29	16	15	11	13	14
Profit Before Tax	488	927	643	972	1,270	1,525	836	1,223	596	470	510	416	398	562	580	359	841	609	180	-46	309	495	488	292	354	849	-1,472	100	362	145	173	67	142	577	696	1,084	428	1,083
Tax	80	235	157	259	404	407	153	335	55	99	107	108	73	129	157	201	308	154	45	52	110	137	130	82	14	207	-319	115	56	29	29	13	25	101	130	185	69	189
Net Profit	408	692	486	745	907	1,080	653	859	549	354	389	309	292	429	425	142	543	446	138	-81	225	364	360	218	316	646	-1,329	530	-36	117	149	40	119	477	549	916	384	889
EPS in ₹	9.07	15.41	10.82	16.57	20.17	23.96	14.49	19.06	12.16	7.84	8.61	6.84	6.47	9.50	9.40	3.14	12.00	9.86	3.04	-1.80	4.98	8.03	7.95	4.82	6.98	14.23	-29.28	11.68	-0.79	2.58	3.27	0.89	2.62	10.48	12.06	20.14	8.43	19.51

Show % Change

Above figures are in Rs. Crores

Balance Sheet

Balance Sheet	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total Assets	11,008	14,236	17,848	18,681	19,690	20,681	21,859	22,313	22,684	24,923
Fixed Assets	2,036	2,345	3,013	3,341	3,373	3,514	3,639	3,690	4,022	4,113
Current Assets	6,452	7,256	9,251	8,717	9,485	10,839	9,617	8,438	7,571	9,288
Capital Work in Progress	490	624	481	1,171	1,199	822	951	947	927	446
Investments	1,654	3,741	6,914	5,363	7,388	7,456	9,563	9,511	9,974	11,581
Other Assets	6,828	7,526	7,441	8,806	7,730	8,888	7,706	8,165	7,761	8,783
Total Liabilities	1,980	2,323	3,068	2,896	2,573	3,207	3,293	4,163	4,272	4,320
Current Liabilities	1,660	1,955	2,566	2,336	1,997	2,556	2,586	3,538	3,628	3,694
Non Current Liabilities	320	368	502	560	576	652	707	625	644	626
Total Equity	9,028	11,913	14,780	15,785	17,117	17,473	18,566	18,150	18,412	20,603
Reserve & Surplus	8,938	11,823	14,690	15,695	17,027	17,383	18,475	18,059	18,321	20,512
Share Capital	90	90	90	90	91	91	91	91	91	91

Show % Change

Above figures are in Rs. Crores

Cash Flow

Cash Flow	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Net Cash Flow	1,452	-1,696	2,252	-52	-50	1,112	-991	-118	27	38
Investing Activities	-1,178	-2,629	-1,941	725	-2,865	-740	-2,508	-372	-1,269	-1,599
Operating Activities	2,852	917	4,352	209	3,111	2,219	1,570	151	1,794	2,504
Financing Activities	-221	17	-160	-987	-295	-368	-53	102	-498	-867

Show % Change

Above figures are in Rs. Crores

Share Holding

% Holding	Mar 2021	Jun 2021	Sept 2021	Dec 2021	Mar 2022	Jun 2022	Sept 2022	Dec 2022	Mar 2023	Jun 2023	Sept 2023	Dec 2023	Mar 2024	Jun 2024
Promoter	46.86 %	46.84 %	46.83 %	46.81 %	46.78 %	47.10 %	47.11 %	47.10 %	47.08 %	47.07 %	47.06 %	47.04 %	47.01 %	46.98 %
FIIs	17.87 %	18.60 %	15.66 %	15.28 %	14.65 %	14.27 %	13.81 %	13.98 %	13.32 %	13.94 %	14.99 %	16.11 %	18.28 %	19.32 %
DIIs	22.29 %	21.81 %	24.46 %	24.84 %	26.91 %	26.90 %	27.63 %	29.38 %	29.21 %	29.36 %	29.42 %	29.73 %	27.76 %	26.78 %
Government	0.29 %	0.28 %	0.28 %	0.28 %	0.29 %	0.29 %	0.00 %	0.00 %	0.00 %	0.00 %	0.01 %	0.01 %	0.01 %	0.01 %
Public / Retail	12.69 %	12.47 %	12.76 %	12.79 %	11.37 %	11.45 %	11.45 %	9.53 %	10.39 %	9.63 %	8.52 %	7.11 %	6.93 %	6.92 %

Show % Change

Peer Comparison Compare Peers on Screener

Competitors	LTP	Market Cap (₹ Cr.)	P/E Ratio	Revenue (₹ Cr.)	YoY Revenue Growth %	Net Profit (₹ Cr.)	YoY Profit Growth %	RSI
Sun Pharmaceutical	1,836.00	4,47,691.91	42.46	49,887.17	12.06	9,648	42.62	61.03
Cipla	1,651.60	1,34,956.56	30.36	26,520.66	14.17	4,155	17.77	60.15
Zydus Life Science	1,079.95	1,11,727.19	26.80	19,831.50	13.82	3,831	30.78	34.07
Dr Reddys Laboratories	6,567.80	1,10,648.92	19.88	28,905.40	12.36	5,578	-0.90	36.38
Lupin	2,224.95	1,03,570.56	45.76	20,141.50	19.94	1,936	77.69	59.35
Mankind Pharma	2,395.60	98,296.04	50.09	10,615.63	19.57	1,942	9.89	53.00
Aurobindo Pharma	1,539.15	90,940.60	25.35	29,559.25	17.55	3,169	61.17	55.58
Alkem Laboratories	6,090.30	74,370.03	34.59	12,978.42	9.84	1,811	91.18	53.74
Glenmark Pharmaceuticals	1,646.05	48,348.71	-	12,653.09	6.58	-1,831	96.52	48.26
Biocon	363.65	45,082.53	28.88	15,621.20	35.25	1,298	478.78	48.38